Core Scientific, Inc. CORZ

17.34 (0.79) (4.36%) as of 25 Sep
Market cap
$5.9B
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash and Short Term Investments
311.38 836.98 69.71 52.24 131.68 —
Receivables
— — 1.00 0.26 1.68 —
Other current assets
584.16 66.98 2.28 0.72 593.09 —
Total current assets
895.54 903.96 97.02 85.10 756.56 —
Property, Plant, Equpment (Net)
1,293.30 433.47 585.43 691.13 597.30 —
Goodwill and Intangible Assets (Total)
— — — 1.70 1,063.96 0.00
Long-term assets (Other)
50.32 24.04 21.87 9.32 21.05 —
Total non-current assets
1,452.11 571.98 615.14 722.58 1,682.30 —
Total Assets
2,347.64 1,475.95 712.16 807.69 2,438.86 0.00
Notes Payable
— — 124.36 36.24 76.00 —
Accounts Payable
126.11 19.27 154.75 53.64 11.62 —
Accrued Expenses
511.96 64.67 179.64 17.95 67.86 —
Current Part of Capital Lease
— — 19.77 — 28.45 0.00
Current Part of Taxes to Pay
— — — — — 0.00
Current Revenue (Deferred)
127.56 18.13 9.83 78.19 136.36 —
Other current liabilities
15.78 32.49 — — — —
Total current liabilities
781.40 134.56 488.42 186.79 320.29 —
Long Term Debt (Total)
1,060.33 1,073.99 719.83 — 714.36 —
Non-current Revenue (Deferred)
428.29 — — — — 0.00
Minority Interests
— — — — — 0.00
Non-current Liabilities (Other)
1,040.37 1,210.44 99.34 1,029.52 63.01 —
Total non-current liabilities
2,528.98 2,284.43 820.67 1,030.24 777.37 —
Total liabilities
3,310.38 2,419.00 1,309.10 1,217.03 1,097.65 0.00
Additional Paid In Capital
3,183.96 2,915.04 1,823.26 1,764.37 1,379.58 0.00
Preferred Stock (Total)
— — — — — 0.00
Common Stock (Net)
0.00 0.00 0.04 0.04 0.03 0.00
Retained Earnings
(4,146.70) (3,858.09) (2,420.24) (2,173.75) (27.43) —
Treasury Stock
— — — — — 0.00
Shareholders Equity (Other)
— — — — — 0.00
Common Equity (Total)
(962.74) (943.05) (596.94) (409.35) 1,341.21 —
Shareholders Equity (Total)
(962.74) (943.05) (596.94) (409.35) 1,341.21 0.00
Shareholders Equity and Liabilities (Total)
2,347.64 1,475.95 712.16 807.69 2,438.86 0.00
Shares (Common)
314.23 292.61 386.88 375.23 271.58 —
Shareholders Equity (Tangible)
(962.74) (943.05) (596.94) (411.05) 277.26 —
Net Debt
748.95 237.01 650.12 (52.24) 582.68 —
Total Debt
1,060.33 1,073.99 719.83 — 714.36 —

Fold the line items

In millions of $ except per-share values · columns are period end dates